Human DEFB119 ELISA kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of human DEFB119 in serum, plasma, tissue homogenates, and other biological fluids.

• Ready-To-Use ELISA Kit
• Detection Range: 0.313 - 20 ng/ml
• Sensitivity: 0.188 ng/ml
• Sample Type: Serum, plasma, tissue homogenates, and other biological fluids
• Assay Precision: Intra-Assay: CV <8%, Inter-Assay: CV <10%

Human DEFB119 ELISA kit (A74759) employs the competitive enzyme immunoassay technique for the quantitative measurement of human DEFB119 in serum, plasma, tissue homogenates, and other biological fluids. The 96-well microtiter plate has been pre-coated with DEFB119 antigen. During the incubation, DEFB119 present in the samples or standards competes with the fixed amount of immobilized DEFB119 for binding sites on the Biotinylated Anti-DEFB119 Antibody. The more DEFB119 present in a sample or standard, the less Biotinylated Anti-DEFB119 Antibody that binds to the plate. Following incubation, unbound Biotinylated Anti-DEFB119 Antibody is removed by washing, and an HRP-Streptavidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is inversely proportional to the amount of DEFB119 present in each sample or standard. The concentration of DEFB119 can then be calculated by reading the O.D. absorbance at 450 nm in a microplate reader and referring to the standard curve.